drugset / Trial / NCT00331240

24-Hour Intraocular Pressure (IOP) Control With Travoprost/Timolol Fixed Combination

NCT00331240 ↗

Phase 3 Completed 32 enrolled Aristotle University Of Thessaloniki
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to compare the short-term (8 week) mean 24-hour intraocular pressure control and safety of TravTim fixed combination given once in the evening with placebo once in the morning versus TravTim given once in the morning with placebo once in the evening in patients with open-angle glaucoma.

Timeline

Start
2006-03
Primary completion
2007-01
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject travoprost/timolol Unknown — —